BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2001
View Archived Issues
Proneuron and Teva to collaborate on development of glatiramer acetate as neuroprotective agent
Read More
DSMB recommends that phase III Theratope study continue
Read More
Purdue develops abuse-resistant analgesic
Read More
MedImmune set to acquire Aviron in USD 1.5 billion deal
Read More
Final phase IIb results of IL-2 GeneMedicine product disappointing
Read More
Oral cromolyn sodium shows good GI absorption in conjunction with Emisphere technology
Read More
FDA approval for intravenous formulation of Avelox
Read More
Antizol receives additional approval in Canada for methanol poisoning
Read More
Shire will not exercise Cytovax MAb product option; continues Cytovaxine development
Read More
Enrollment completed for phase II trial of ZYC-101a in HPV-associated cervical dysplasia
Read More
Incara and FDA meet to discuss plans for liver cell program prior to IND submission
Read More
Amgen's OPG as effective as pamidronate in reducing bone resorption in multiple myeloma patients
Read More
Sugen presents in vitro data on indolinone related to SU-5416 at Hematology meeting
Read More
RWJ-58259 effectively blocks thrombosis in primate model
Read More
Merger of Nippon Roche and Chugai scheduled for next year
Read More
Promise of plant extract in sickle cell disease therapy upheld by preclinical data
Read More
PSC-833, an MDR modulator, examined in untreated AML patients of different age groups
Read More
Tubulin polymerization inhibitor effective against refractory tumors in clinical trials
Read More
Safety data from phase II trial in lymphoma patients reported for apolizumab
Read More
FDA lifts hold on phase III trial of Aptosyn + Taxotere
Read More
Proof-of-principle study completed for P-57 as treatment for obesity
Read More
New histamine H3 receptor ligands designed by Ortho-McNeil
Read More
Inhibitors of SGLT2 under study at BMS as potential antidiabetic agents
Read More
Peptides binding CEA useful for imaging and treating tumors
Read More
Takeda scientists identify compounds which increase sAPP secretion
Read More
Highly potent and nontoxic TNF-alpha production inhibitors reported by Sankyo
Read More
Herpesvirus polymerase inhibitors described in recent patent
Read More